HR

Hollings C. Renton

Chairman of the Board at Portola Pharmaceuticals

Hollings C. Renton previously served as president and chief executive officer, director, and chairman of the board of Onyx Pharmaceuticals, Inc. until he retired in 2008. From 1991 to 1993, he served as president and chief operating officer of Chiron Corporation, a pharmaceutical company, following its acquisition of Cetus Corporation. Prior to the acquisition, he served as president of Cetus Corporation from 1990 to 1991, as chief operating officer from 1987 to 1990, and as chief financial officer from 1983 to 1987. Mr. Renton currently serves as a director at AnaptysBio and Zymeworks Inc. He previously served as a director of Cepheid, Inc., Kythera Biopharmaceuticals, Rigel Pharmaceuticals, Inc., Affymax Inc., Sangstat Medical Corporation, Special Olympics Northern California, and the Biotechnology Industry Organization. Mr. Renton holds a B.S. in mathematics from Colorado State University and an M.B.A. from the University of Michigan.

Timeline

  • Chairman of the Board

    Current role